about
Time trends and forecasts of body mass index from repeated cross-sectional data: a different approach.The cost-effectiveness of increasing alcohol taxes: a modelling study.Estimating and comparing incidence and prevalence of chronic diseases by combining GP registry data: the role of uncertaintyCo-occurrence of diabetes, myocardial infarction, stroke, and cancer: quantifying age patterns in the Dutch population using health survey data.Disease prevention: saving lives or reducing health care costs?DYNAMO-HIA--a Dynamic Modeling tool for generic Health Impact AssessmentsDisability weights for comorbidity and their influence on health-adjusted life expectancyEstimating health-adjusted life expectancy conditional on risk factors: results for smoking and obesity.Decomposing cross-country differences in quality adjusted life expectancy: the impact of value sets.Targeted versus universal prevention. a resource allocation model to prioritize cardiovascular preventionDynamic effects of smoking cessation on disease incidence, mortality and quality of life: The role of time since cessation.Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions?Cost-effectiveness of lifestyle modification in diabetic patientsHealth inequalities in the Netherlands: trends in quality-adjusted life expectancy (QALE) by educational level.Forecasting differences in life expectancy by education.Future Costs, Fixed Healthcare Budgets, and the Decision Rules of Cost-Effectiveness Analysis.Time to death and the forecasting of macro-level health care expenditures: some further considerations.You Only Die Once: Accounting for Multi-Attributable Mortality Risks in Multi-Disease Models for Health-Economic Analyses.Forecasting lifetime and aggregate long-term care spending: accounting for changing disability patterns.Lifestyle intervention: from cost savings to value for money.Lipid-lowering treatment for all could substantially reduce the burden of macrovascular complications of diabetes patients in the Netherlands.Future costs in economic evaluation. A comment on Lee.The Impact of Hospital Payment Schemes on Healthcare and Mortality: Evidence from Hospital Payment Reforms in OECD Countries.Does living longer in good health facilitate longer working lives? The relationship between disability and working lives.Trends in Dutch hospital spending by age and disease 1994-2010.Exploring the influence of proximity to death on disease-specific hospital expenditures: a carpaccio of red herrings.Indirect estimation of chronic disease excess mortality.Pharmacoeconomic guidelines should prescribe inclusion of indirect medical costs! A response to Grima et Al.Weight change and incident diabetes: addressing an unresolved issue.Unrelated Future Costs and Unrelated Future Benefits: Reflections on NICE Guide to the Methods of Technology Appraisal.Should cost effectiveness analyses for NICE always consider future unrelated medical costs?Quality of life and time to death: have the health gains of preventive interventions been underestimated?Did the health of the Dutch population improve between 2001 and 2008? Investigating age- and gender-specific trends in quality of life.Health care input constraints and cost effectiveness analysis decision rules.The DYNAMO-HIA model: an efficient implementation of a risk factor/chronic disease Markov model for use in Health Impact Assessment (HIA).Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation among Dutch students.Economic evaluation and the postponement of health care costs.Probabilistic sensitivity analysis: be a Bayesian.Future unrelated medical costs need to be considered in cost effectiveness analysis.A cost-effectiveness threshold based on the marginal returns of cardiovascular hospital spending
P50
Q30557938-735B0A06-937F-46D2-83D3-5B8217C9D3C2Q33387950-F819C23A-B5CF-463A-A3BD-B91BB991973EQ33846637-53B46087-9C07-4DD8-B4D0-215AED349283Q34008014-490D8E5B-1E24-4B66-851A-AF3E3030A98AQ34035101-C6C8B2F6-97C7-44AD-8EC5-74EA09E0B64EQ34270554-4057C702-6AF1-408A-8DA2-67D891D99F69Q34872562-C2D4BEA8-175B-41DE-A887-FB0EF550B482Q35131146-0BD3FC97-7D81-46D8-81E1-C042AB8513D4Q35137275-3CE43D4C-D035-412B-8C6C-3110074BBE39Q35431592-042D77A4-2148-4522-B323-272E48338305Q36494908-B91CCCEA-8AC1-493F-A3F9-76057EF1924FQ37269339-060AC344-7B51-4FA2-A7AE-28D731A41701Q37269534-EB57C4BB-8231-4313-9477-D252D3D7F9F2Q38408481-BA6EED1A-B170-42F6-BDE7-7CA0C8875B74Q38884818-65451269-43B5-4B32-B7AB-B1A1326B1AF0Q39069173-091FB78B-D039-4359-8F86-A84064F8F30AQ39548901-49CEFC92-7E27-488E-AED3-52F8184CC853Q39609247-13F7C13A-379F-4EA5-A0CB-AA599BF5FF1FQ39641854-19D94E86-AABC-455E-952C-DBAB41601507Q39956669-DBBAE9E4-5C46-4992-9473-5477242BE29AQ40040134-049144F6-1F60-4BC4-8EC0-EE0A4E886D66Q40041029-666ECD70-162A-465D-A7DB-524B671B0BAFQ40829976-C7B03FB0-6112-46C0-BD77-200BB9058AF6Q41100539-25CC125E-D0D5-4BBE-9EE5-0CBE7D008BBAQ41735432-6D2B9BED-635D-4785-95AE-F2F4D6EF2F4AQ43710766-BD23D3F6-DB20-447B-AAD3-A31966FBD55FQ44023119-FB6DEA81-BA07-4AD1-8C0E-14F8286CD6B5Q44084668-FD3E25FF-3269-40F1-8FB2-DBCD1916E7A2Q47425261-B63A184C-8ADA-4708-B643-0E27EEED37FAQ47753545-CEC391E6-A4AB-44F8-97A0-FC88F10C6DFAQ47845791-040D39B0-E710-4E6C-A387-F0786132CF37Q48061868-C7E4BE4F-DF75-4561-9B2E-5D88BA6CB79CQ48065523-2DA47F6E-8EE6-4038-94E0-2A1AE64007A5Q50111242-CB150C25-836D-414E-ACA5-2C9B8997550DQ50120432-75724C45-F2B2-4254-BC40-14113064441AQ50147730-D23E32C7-5723-4973-A53D-34D1108E9ED4Q50549440-093D5A4E-8112-43BB-B65B-DE5C13B47C15Q51799724-42F20A5D-CB5D-4EA3-B965-AA06EB33B06FQ52578759-117CA605-9ACB-4E22-B901-CD7998051F9DQ57055566-890664D3-970D-4331-9F9F-9E4313EF3871
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Pieter M van Baal
@ast
Pieter M van Baal
@en
Pieter M van Baal
@es
Pieter M van Baal
@nl
type
label
Pieter M van Baal
@ast
Pieter M van Baal
@en
Pieter M van Baal
@es
Pieter M van Baal
@nl
prefLabel
Pieter M van Baal
@ast
Pieter M van Baal
@en
Pieter M van Baal
@es
Pieter M van Baal
@nl
P106
P1153
14055256000
55852485000
P21
P31
P496
0000-0001-9913-2393